
Thomas Hefti
individual
About
Thomas Hefti is a Swiss life sciences and medical-device executive serving as CEO of Bottneuro AG, a neurotechnology company focused on neurocognitive disorders including Alzheimer's disease. Bottneuro's announcement says he previously led the international business of Novocure, a Swiss-based medical device company. Older public material also places him in a leadership role at Krefatec Solutions AG in Switzerland.
Areas of interest
neurotechbrain healthAlzheimer's diseasemedical devicesdigital therapeuticspharma commercializationhealthtech